FDA Inspection 1009661 — Aimee Eyvazzadeh, MD, Inc.
The FDA completed an inspection of Aimee Eyvazzadeh, MD, Inc. on April 13, 2017 in San Ramon, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 13, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- San Ramon, CA (United States)